NCT04080297View on ClinicalTrials.gov

Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 10, 2014

Primary Completion Date

July 28, 2014

Study Completion Date

July 28, 2014

Conditions
Vasomotor Symptoms (VMS)
Interventions
DRUG

oral capsule of Q-122

Sponsors

Lead Sponsor

Que Oncology
All Listed Sponsors
lead

Que Oncology

INDUSTRY